Isodur Xl (Isosorbide 5 Mononitrate)

The molecule releases nitric oxide after oral absorption. Nitric oxide activates guanylate cyclase in vascular smooth muscle, increasing cyclic GMP levels. Elevated cyclic GMP causes relaxation of arteries and veins, reducing preload and afterload, which in turn decreases myocardial oxygen consumption and alleviates angina.

Dosing of Isodur XL is individualized. The prescribing clinician determines the appropriate strength and frequency based on the patient’s clinical condition, response, and tolerance. Patients should follow the exact regimen written on their prescription and not adjust the dose without medical advice.

Safety data for isosorbide 5‑mononitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Isodur XL, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Isodur XL belongs to the nitrate class, offering once‑daily extended‑release dosing, which can improve adherence compared with short‑acting nitrates like nitroglycerin that require multiple daily doses. Unlike beta‑blockers, nitrates primarily act by vasodilation rather than heart‑rate reduction, making them suitable for patients who cannot tolerate beta‑blockade.

Store the tablets at temperatures below 25 °C in their original blister pack, protecting them from moisture and direct sunlight. Do not expose the product to excessive heat or humidity, and keep it out of reach of children. No special refrigeration is required for this oral extended‑release formulation.

Isodur XL is taken orally as a whole extended‑release tablet. Swallow the tablet whole with a glass of water; do not crush, chew, or split it, as this can destroy the controlled‑release mechanism and increase the risk of side effects.

The most serious adverse events include severe hypotension, syncope (fainting), and rare allergic reactions such as rash, swelling, or breathing difficulty. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, or signs of an allergic response.

Isodur XL is contraindicated in patients who are currently taking other nitrate medications, have severe hypotension (systolic blood pressure below 90 mmHg), or have known hypersensitivity to isosorbide derivatives. Caution is also advised for individuals with recent phosphodiesterase‑5 inhibitor use.